RTSM Resources

  1. Why The Future Looks Bright For eCOA In Clinical Trials 5/16/2023

    Unearth the ways electronic clinical outcome assessment technology is revolutionizing data collection, improving patient experiences, and enhancing trial outcomes.

  2. 7 Key Considerations For Designing The Optimal IRT/RTSM 11/21/2024

    Sponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.

  3. 3 Study Areas Where Your IRT Vendor Should Do More 11/21/2024

    Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.

  4. Driving Customer Profitability With Enterprise Platform, Pricing 2/29/2024

    Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.

  5. IRT? RTSM? What's The Difference? 10/4/2024

    What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?

  6. The Present And Future Of Study Supply Management 6/17/2024

    Gain expert insights on the future of RTSM strategy and its evolution with the changing clinical supply and technology landscape in our webinar.

  7. How Heron Therapeutics Sped Up Database Creation 12/2/2022

    Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.

  8. Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial 1/16/2024

    Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.

  9. Our Unified Platform Serves As eSource For COVID Treatment Trial 6/17/2024

    Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.

  10. End-To-End Clinical Data Flow 6/24/2024

    Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.